SCI Pharmtech, Inc. (TPE: 4119)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
84.80
+0.60 (0.71%)
Jan 20, 2025, 1:30 PM CST

SCI Pharmtech Statistics

Total Valuation

SCI Pharmtech has a market cap or net worth of TWD 10.13 billion. The enterprise value is 10.69 billion.

Market Cap 10.13B
Enterprise Value 10.69B

Important Dates

The next estimated earnings date is Tuesday, March 18, 2025.

Earnings Date Mar 18, 2025
Ex-Dividend Date n/a

Share Statistics

SCI Pharmtech has 119.51 million shares outstanding. The number of shares has increased by 10.21% in one year.

Current Share Class n/a
Shares Outstanding 119.51M
Shares Change (YoY) +10.21%
Shares Change (QoQ) +0.17%
Owned by Insiders (%) 6.57%
Owned by Institutions (%) 3.86%
Float 68.68M

Valuation Ratios

The trailing PE ratio is 20.78.

PE Ratio 20.78
Forward PE n/a
PS Ratio 7.10
PB Ratio 1.87
P/TBV Ratio 1.88
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 29.90, with an EV/FCF ratio of -15.35.

EV / Earnings 22.09
EV / Sales 7.57
EV / EBITDA 29.90
EV / EBIT 75.99
EV / FCF -15.35

Financial Position

The company has a current ratio of 2.35, with a Debt / Equity ratio of 0.20.

Current Ratio 2.35
Quick Ratio 1.56
Debt / Equity 0.20
Debt / EBITDA 2.93
Debt / FCF -1.58
Interest Coverage 26.66

Financial Efficiency

Return on equity (ROE) is 10.14% and return on invested capital (ROIC) is 1.73%.

Return on Equity (ROE) 10.14%
Return on Assets (ROA) 1.56%
Return on Capital (ROIC) 1.73%
Revenue Per Employee 5.91M
Profits Per Employee 2.03M
Employee Count 239
Asset Turnover 0.22
Inventory Turnover 1.82

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -10.74% in the last 52 weeks. The beta is -0.24, so SCI Pharmtech's price volatility has been lower than the market average.

Beta (5Y) -0.24
52-Week Price Change -10.74%
50-Day Moving Average 92.08
200-Day Moving Average 90.51
Relative Strength Index (RSI) 27.86
Average Volume (20 Days) 186,003

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, SCI Pharmtech had revenue of TWD 1.41 billion and earned 484.24 million in profits. Earnings per share was 4.08.

Revenue 1.41B
Gross Profit 383.22M
Operating Income 159.94M
Pretax Income 584.24M
Net Income 484.24M
EBITDA 374.69M
EBIT 159.94M
Earnings Per Share (EPS) 4.08
Full Income Statement

Balance Sheet

The company has 543.51 million in cash and 1.10 billion in debt, giving a net cash position of -560.12 million or -4.69 per share.

Cash & Cash Equivalents 543.51M
Total Debt 1.10B
Net Cash -560.12M
Net Cash Per Share -4.69
Equity (Book Value) 5.42B
Book Value Per Share 45.36
Working Capital 1.23B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 96.11 million and capital expenditures -793.00 million, giving a free cash flow of -696.89 million.

Operating Cash Flow 96.11M
Capital Expenditures -793.00M
Free Cash Flow -696.89M
FCF Per Share -5.83
Full Cash Flow Statement

Margins

Gross margin is 27.11%, with operating and profit margins of 11.32% and 34.26%.

Gross Margin 27.11%
Operating Margin 11.32%
Pretax Margin 41.34%
Profit Margin 34.26%
EBITDA Margin 26.51%
EBIT Margin 11.32%
FCF Margin n/a

Dividends & Yields

This stock pays an annual dividend of 1.25, which amounts to a dividend yield of 1.48%.

Dividend Per Share 1.25
Dividend Yield 1.48%
Dividend Growth (YoY) n/a
Years of Dividend Growth 1
Payout Ratio 30.85%
Buyback Yield -10.21%
Shareholder Yield -8.72%
Earnings Yield 4.81%
FCF Yield -6.88%
Dividend Details

Stock Splits

The last stock split was on July 27, 2023. It was a forward split with a ratio of 1.125.

Last Split Date Jul 27, 2023
Split Type Forward
Split Ratio 1.125

Scores

SCI Pharmtech has an Altman Z-Score of 4.43.

Altman Z-Score 4.43
Piotroski F-Score n/a